April 22, 2024 Suvretta Capital Management, LLC 540 Madison Ave., 7th Floor New York, NY 10022 Ladies and Gentlemen:Stock Purchase Agreement • May 13th, 2024 • Benitec Biopharma Inc. • Pharmaceutical preparations
This letter agreement is entered into by and among Suvretta Capital Management, LLC (“Suvretta”) and Benitec Biopharma Inc. (“Benitec” or the “Company” and, together with Suvretta, the “Parties”). Concurrently with the execution of this letter agreement, the Parties are entering into that certain Stock Purchase Agreement, dated as of April 17, 2024 by and among Suvretta, Benitec, and the other parties thereto (the “Purchase Agreement”), and that certain Voting Commitment Agreement, dated as of April 22, 2024, by and among Benitec, Suvretta, and the other parties thereto (the “Voting Commitment Agreement,” and together with the Purchase Agreement, the “Agreements”). Prior to entering the Purchase Agreement, Suvretta and its affiliates are the beneficial owners of (i) 15,181,359 common warrants of the Company, exercisable for 5,769,583 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) in the amounts and at the exercise prices set forth in Schedule A at
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 13th, 2024 • Benitec Biopharma Inc. • Pharmaceutical preparations
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
